Horizon Pharma acquires Crealta for $510M; gains arthritis drug
In the acquisition, Horizon gains rights to Krystexxa, a drug that treats an orphan disease called chronic refractory gout that affects some 50,000 people in the U.S.
Knee replacements: The new fad?
Bad knees are a common conversation starter when climbing the stairs alongside a middle-aged stranger. But in reality, people seem to be jumping the gun on dealing with the issue. Increasing numbers of knee replacements are startling, and the surgery doesn’t necessarily yield positive results. The New York Times reports: There’s no doubt that knee replacements […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Shire confirms in talks with AbbVie on takeover bid
(Reuters) – Shire Plc on Friday confirmed it has held a meeting with U.S. drugmaker AbbVie Inc to discuss AbbVie’s takeover bid for the Dublin-based maker of drugs for rare diseases. Shire, in a release, did not provide any additional information about the meeting, saying it would provide a further update “when appropriate.” It added […]
Healthcare design firm creates user-friendly auto-injector rheumatoid arthritis patients
A British healthcare design firm has come out with a new drug-delivery device to add to its innovative portfolio: an auto-injector for rheumatoid arthritis patients. On its head, this might not sound super-glamorous for a firm like Cambridge Consultants, but the design of Aira is much more user-friendly than many other models currently on the […]
Want to solve your men’s health issue? Grow a mustache, join the Movember movement
Doctor Mike Evans’ Youtube Channel is one of my favorites. Watching “23 1/2 hours” changed my perspective on how I should be treating my body. Now, he and Movember CEO Adam Garone (TED Talk here) have created a video to promote men’s health, facial hair and Movember. This November, it asks men to find ways […]
Entrepreneur’s arthritic grandmother inspires a medtech fork + $9,500 IndieGogo campaign
When Rise Assistive Devices CEO Vadim Gordin tried to buy his grandmother a fork she could use more easily, what he found were forks jammed into bicycle handles. He used his biomedical engineering background to construct and 3-D print what would become the Easy Fork for her. What he thought would be a one-off has […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Shock absorbers for the human body? Implant could help active patients avoid total knee replacements longer
Think shock absorbers for the human body. Moximed could help active and young patients who have osteoarthritis prolong the amount of time before total knee replacement. The Heyward, Calif.-based company’s Kinespring Knee Implant System is a medical device that absorbs part of the load put on the knee, without changing anatomy. The device is positioned […]
Synthetic cartilage implant designed to restore natural joint mechanics in osteoarthritis patients
With an ongoing clinical trial and a new investment, startup Cartiva Inc. is well on its way to bringing a less invasive, motion-preserving alternative to joint fusion to patients in the U.S. The Alpharetta, Georgia, company just landed a $4.3 million investment led by New Enterprise Associates. It will use the funds to continue its […]
With a band of biotech collaborators, RuiYi sets sail developing new biologic drugs for China
The La Jolla, California, biotech formerly known as Anaphore is looking a little different these days. Under the leadership of former Fate Therapeutics CEO Paul Grayson, Anaphore changed its name to RuiYi Inc., honed its focus from developing broader classes of proteins to new biologic drugs for the Chinese market, and set up a four-way […]
CHTP’s arthritis drug fails phase 2; now everything rides on Northera
Chelsea Therapeutics‘ (NASDAQ:CHTP) rheumatoid arthritis treatment failed in phase 2 clinical trials and leaves the beleaguered drug developer to focus its remaining resources on an orphan drug candidate that has already fallen short of regulatory approval. The experimental rheumatoid arthritis drug CH-4051 demonstrated some effect on patients, but did not prove better than existing rheumatoid […]
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
How arthritis drug Vimovo shaped POZN’s strategy on its heart drug
Arthritis represents a large medical need but it is served by several products that carry gastrointestinal risks. Arthritis treatment Vimovo, developed as an alternative that’s easier on the stomach, was intended to address that need. Backed by the marketing muscle of pharma giant AstraZeneca (NYSE:AZN), Pozen (NASDAQ:POZN), which developed the drug, had every expectation it […]
GSK grips arthritis compounds from drug partner Galapagos
GlaxoSmithKline (NYSE:GSK) is strengthening its prospects of developing a new arthritis treatment by licensing two anti-inflammatory compounds from drug partner Galapagos NV (OTC:GLPYY). Belgium-based Galapagos said GSK has exercised its option on compounds GLPG0778 and GLPG0555, both of which were developed within the partnership. Galapagos now stands to receive from GSK an option fee payment […]
Cardinal Health launches infusion therapy tool for rheumatology practices
Pharmaceuticals distributor Cardinal Health (NYSE:CAH) has launched a web-based tool to help rheumatology practices better manage infusion therapy patients. Cardinal’s new InfusaTrack software is designed to make it easier for community rheumatology practices to offer in-office infusion therapy, which involves administering medication through a needle or catheter for patients whose conditions are too severe to […]
GSK licenses ChemoCentryx arthritis treatment to bolster drug pipeline
GlaxoSmithKline (NYSE:GSK) is strengthening its drug pipeline with an experimental arthritis treatment from drug partner ChemoCentryx. The pharmaceutical giant has exercised an option for an exclusive license to develop ChemoCentryx’s investigational drug CCX354, which recently produced positive phase 2 clinical trial results in a study of patients with rheumatoid arthritis. Under terms of the collaboration […]
De-Stressing the Holidays and Enjoying the Season More
We’re in the thick of it now. The thick of the holidays, that is. The season offers wonderful opportunities to connect with family and friends combined with a plethora of ways to amplify stress. For people with arthritis, or any chronic disease, stress can make their pain worse. And fatigue, which often goes hand-in-hand with […]